Vaxart, Inc. (NASDAQ:VXRT) Q2 2025 Earnings Call Transcript August 13, 2025
Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.09.
Operator: Greetings, and welcome to the Vaxart Business Update and Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the webcast over to your host, Ed Berg, Senior Vice President and General Counsel. Please go ahead.
Edward...
